Literature DB >> 2570017

Risks of fetal cystic fibrosis based on linkage disequilibrium data.

S Holloway1, D J Brock.   

Abstract

First-trimester prenatal diagnosis of cystic fibrosis depends on tissues being available from a previous affected child for determination of the phase relationship of DNA markers. If no such tissues are available, it is possible to estimate the risks of a couple producing an affected child from the distribution of haplotypes showing linkage disequilibrium with the cystic fibrosis gene. We have calculated all the fetal risk subsets from the various parental haplotype combinations for the restriction fragment length polymorphisms identified by the KM.19/PstI and XV-2c/TaqI systems. We conclude that only in a limited number of parental combinations are the fetal risks sufficiently high or sufficiently low to be used in prenatal diagnosis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2570017     DOI: 10.1007/BF00274147

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  12 in total

1.  Use of linkage disequilibrium data in prenatal diagnosis of cystic fibrosis.

Authors:  L Strain; A Curtis; M Mennie; S Holloway; D J Brock
Journal:  Hum Genet       Date:  1988-09       Impact factor: 4.132

2.  Experience with new DNA markers for the diagnosis of cystic fibrosis.

Authors:  A L Beaudet; J E Spence; M Montes; W E O'Brien; X Estivill; M Farrall; R Williamson
Journal:  N Engl J Med       Date:  1988-01-07       Impact factor: 91.245

3.  Allelic association of the cystic fibrosis locus and two DNA markers, XV2c and KM19, in 55 German families.

Authors:  M Krawczak; D S Konecki; J Schmidtke; M Dück; W Engel; W Nützenadel; F K Trefz
Journal:  Hum Genet       Date:  1988-09       Impact factor: 4.132

4.  Prenatal diagnosis of cystic fibrosis where single affected child has died: Guthrie spots and microvillar enzyme testing.

Authors:  I McIntosh; L Strain; D J Brock
Journal:  Lancet       Date:  1988-11-05       Impact factor: 79.321

5.  Prenatal diagnosis of cystic fibrosis where single affected child has died.

Authors:  G I te Meerman; L P ten Kate; J M Cobben; T von Essen; C H Buys; D Halley
Journal:  Lancet       Date:  1988-09-24       Impact factor: 79.321

6.  Prenatal diagnosis of cystic fibrosis by DNA amplification for detection of KM-19 polymorphism.

Authors:  G L Feldman; R Williamson; A L Beaudet; W E O'Brien
Journal:  Lancet       Date:  1988-07-09       Impact factor: 79.321

7.  Patterns of polymorphism and linkage disequilibrium for cystic fibrosis.

Authors:  X Estivill; P J Scambler; B J Wainwright; K Hawley; P Frederick; M Schwartz; M Baiget; J Kere; R Williamson; M Farrall
Journal:  Genomics       Date:  1987-11       Impact factor: 5.736

8.  A candidate for the cystic fibrosis locus isolated by selection for methylation-free islands.

Authors:  X Estivill; M Farrall; P J Scambler; G M Bell; K M Hawley; N J Lench; G P Bates; H C Kruyer; P A Frederick; P Stanier
Journal:  Nature       Date:  1987 Apr 30-May 6       Impact factor: 49.962

9.  Prenatal diagnosis of cystic fibrosis by microvillar enzyme assay on a sequence of 258 pregnancies.

Authors:  D J Brock; H A Clarke; L Barron
Journal:  Hum Genet       Date:  1988-03       Impact factor: 4.132

10.  First-trimester prenatal diagnosis of cystic fibrosis using fibroblasts from a deceased index child to establish haplotypes.

Authors:  A Curtis; L Strain; M Mennie; S Holloway; J A Raeburn; G T Besley; D J Brock
Journal:  Prenat Diagn       Date:  1988-10       Impact factor: 3.050

View more
  1 in total

1.  Gradient of distribution in Europe of the major CF mutation and of its associated haplotype. European Working Group on CF Genetics (EWGCFG).

Authors: 
Journal:  Hum Genet       Date:  1990-09       Impact factor: 4.132

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.